Klinger H, Johnson M A, Park J H. "一种的合成方法" [P]. US Patent, US 10350572 B2, 2025-10-24.
发明人张德明,林芳,刘建华. "Method for the Synthesis of 5-(1-Methylcyclopropyl)pyridazin-3(2H)-one" [P]. 中国发明专利, 专利号 CN 112033967 A, 授权公告日 2016-06-11.
Thompson G K, Anderson J P, Brown S R. "A Process for Preparing High-Purity 5-(1-Methylcyclopropyl)pyridazin-3(2H)-one" [P]. US Patent, US 9555494 B2, 2025-09-12.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Chromatogr. A, 2010, 948, 8382-8409.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Environ. Sci. Technol., 2019, 596, (8), 2973-2980.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of 5-(1-Methylcyclopropyl)pyridazin-3(2H)-one Using HRMS and NMR". Biomed. Chromatogr., 2013, 645, (4), 5203-5207.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2014, 1104, (7), 9775-9785.